Since ride-sharing service Grab took over Uber, fares have increased while service has deteriorated, the country’s antitrust watchdog said Monday, May 28.
The Philippine Competition Commission (PCC) revealed there was a “substantial lessening of competition” based on a survey that it commissioned as part of its review of the merger.
“Post-transaction prices of Grab indicate that prices are increasing, while quality of service is deteriorating, to the detriment of the riding public,” the PCC said.
In March, Grab acquired Uber’s Southeast Asian assets in exchange for the US-based company taking a 27.5% stake in Grab’s operations in the region. At the time, the PCC ordered that the ride-hailing companies suspend the deal until it had completed a review.
Uber had ceased operating in the country to comply with an order by the country’s transport regulator following the expiration of its license as a transportation network.
Based on its findings, the antitrust watchdog said the merger allowed Grab to control more than 90% of the ride-hailing market and that new entrants would not constrain the Southeast Asian company’s dominance of the market.
Full Content: Asian Review
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas